ArticleNutrients2022

Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats.

Yujie Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.